Expression profile of endothelin 1 and its receptor endothelin receptor A in papillary thyroid carcinoma and their correlations with clinicopathologic characteristics

Annals of Diagnostic Pathology

Volumn 18, Issue 2, 2014, Pages 43-48

  Irani, Soussan ^a   Salajegheh, Ali ^a   Gopalan, Vinod ^a   Smith, Robert Anthony ^a   Lam, Alfred King Yin ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

Endothelin 1; Endothelin receptor A; ET 1; Papillary thyroid carcinoma

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID CARCINOMA; TUMOR CLASSIFICATION; VERY ELDERLY; YOUNG ADULT;

ENDOTHELIN 1; ENDOTHELIN RECEPTOR A; ET(A)R; ET-1; PAPILLARY THYROID CARCINOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; CARCINOMA, PAPILLARY; COHORT STUDIES; ENDOTHELIN-1; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; RECEPTOR, ENDOTHELIN A; RNA, MESSENGER; RNA, NEOPLASM; THYROID GLAND; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84896400609     PISSN: 10929134     EISSN: 15328198     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2013.11.001     Document Type: Article

References (34)

1. A.K.Y. Lam, C.Y. Lo, and K.S.L. Lam Papillary carcinoma of thyroid: a 30-year clinicopathological review of the histological variants Endocr Pathol 16 2005 323 330.
2. K.Y. Lam, C.Y. Lo, K.W. Chan, and K.Y. Wan Insular and anaplastic carcinoma of the thyroid: a 45-year comparative study at a single institution and a review of the significance of p53 and p21 Ann Surg 231 2000 329 338.
3. A. Salajegheh, R.A. Smith, K. Kasem, V. Gopalan, M.R. Nassiri, and R. William et al. Single nucleotide polymorphisms and mRNA expression of VEGF-A in papillary thyroid carcinoma: potential markers for aggressive phenotypes Eur J Surg Oncol 37 2011 93 99.
4. X.M. Yu, C.Y. Lo, A.K. Lam, B.H. Lang, P. Leung, and J.M. Luk The potential clinical relevance of serum vascular endothelial growth factor (VEGF) and VEGF-C in recurrent papillary thyroid carcinoma Surgery 144 2008 934 940.
5. X.M. Yu, C.Y. Lo, A.K. Lam, P. Leung, and J.M. Luk Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma Ann Surg 247 2008 483 489.
6. X.M. Yu, C.Y. Lo, W.F. Chan, K.Y. Lam, P. Leung, and J.M. Luk Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases Clin Cancer Res 11 2005 8063 8069.
7. A. Salajegheh, S. Pakneshan, A. Rahman, E. Dolan-Evans, S. Zhang, and E. Kwong et al. Co-regulatory potential of VEGF-A and VEGF-C in thyroid carcinoma Hum Pathol 44 2013 2204 2212.
8. S. Motte, K. McEntee, and R. Naeije Endothelin receptor antagonists Pharmacol Ther 110 2006 386 414.
9. A. Bagnato, and L. Rosanò The endothelin axis in cancer Int J Biochem Cell Biol 40 2008 1443 1451.
10. S. Irani, A. Salajegheh, R.A. Smith, and A.K. Lam A review of the profile of endothelin axis in cancer and its management Crit Rev Oncol Hematol 2014 (in press).
11. L. Peduto Eberl, R. Bovey, and L. Juillerat-Jeanneret Endothelin-receptor antagonists are proapoptotic and antiproliferative in human colon cancer cells Br J Cancer 88 2003 788 795.
12. L. Rosanò, F. Spinella, and D. Salani et al. Therapeutic targeting of the endothelin a receptor in human ovarian carcinoma Cancer Res 63 2003 2447 2453.
13. J.B. Nelson, K. Chan-Tack, S.P. Hedican, S.R. Magnuson, T.J. Opgenorth, and G.S. Bova et al. Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer Cancer Res 56 1996 663 668.
14. L. Rosanò, F. Spinella, and A. Bagnato The importance of endothelin axis in initiation, progression, and therapy of ovarian cancer Am J Physiol Regul Integr Comp Physiol 299 2010 R395 R404.
15. A. Bagnato, F. Spinella, and L. Rosanò Emerging role of the endothelin axis in ovarian tumor progression Endocrinol Relat Cancer 12 2005 761 772.
16. A. Bagnato, D. Salani, and V. Di Castro et al. Expression of endothelin 1 and endothelin A receptor in ovarian carcinoma: evidence for an autocrine role in tumor growth Cancer Res 59 1999 720 727.
17. F. Spinella, L. Rosanò, V. Di Castro, P.G. Natali, and A. Bagnato Endothelin-1 induces vascular endothelial growth factor by increasing hypoxia-inducible factor-1alpha in ovarian carcinoma cells J Biol Chem 277 2002 27850 27855.
18. L. Boldrini, S. Gisfredi, and S. Ursino et al. Expression of endothelin-1 is related to poor prognosis in non-small cell lung carcinoma Eur J Cancer 41 2005 2828 2835.
19. W. Jiao, J. Xu, J. Zheng, Y. Shen, L. Lin, and J. Li Elevation of circulating big endothelin-1: an independent prognostic factor for tumor recurrence and survival in patients with esophageal squamous cell carcinoma BMC Cancer 8 2008 334.
20. P. Wülfing, C. Kersting, and J. Tio et al. Endothelin-1-, endothelin-A-, and endothelin-B-receptor expression is correlated with vascular endothelial growth factor expression and angiogenesis in breast cancer Clin Cancer Res 10 2004 2393 2400.
21. M. Lenziardi, P. Viacava, and I. Fiorini et al. Presence of endothelin-1 in the normal and pathological human thyroid J Endocrinol Invest 18 1995 336 340.
22. J.E. Donckier, J. Mertens-Strijthagen, and B. Flamion Role of the endothelin axis in the proliferation of human thyroid cancer cells Clin Endocrinol (Oxf) 67 2007 552 556.
23. J.E. Donckier, L. Michel, R. Van Beneden, M. Delos, and X. Havaux Increased expression of endothelin-1 and its mitogenic receptor ETA in human papillary thyroid carcinoma Clin Endocrinol (Oxf) 59 2003 354 360.
24. J.E. Donckier, L. Michel, M. Delos, X. Havaux, and R. Van Beneden Interrelated overexpression of endothelial and inducible nitric oxide synthases, endothelin-1and angiogenic factors in human papillary thyroid carcinoma Clin Endocrinol(Oxf) 64 2006 703 710.
25. R. DeLellis, R. Lloyd, P. Heitz, and C. Eng World Health Organization classification of tumours: pathology and genetics of tumours of endocrine organs 2004 IARC (International Agency for Research on Cancer) Press Lyon.
26. L. Sobin, and C. Wittekind International Union Against Cancer (UICC) TNM classification of malignant tumours 7th ed. 2009 Springer Press Berlin.
27. D. Salani, V. Di Castro, and M.R. Nicotra et al. Role of endothelin-1 in neovascularization of ovarian carcinoma Am J Pathol 157 2000 1537 1547.
28. R. Montironi, R. Mazzucchelli, and F. Barbisan et al. Immunohistochemical expression of endothelin-1 and endothelin-A and endothelin-B receptors in high-grade prostatic intraepithelial neoplasia and prostate cancer Eur Urol 52 2007 1682 1689.
29. K. Alanen, D.X. Deng, and S. Chakrabarti Augmented expression of endothelin-1, endothelin-3 and the endothelin-B receptor in breast carcinoma Histopathology 36 2000 161 167.
30. P. Wülfing, R. Diallo, and C. Kersting et al. Expression of endothelin-1, endothelin-A, and endothelin-B receptor in human breast cancer and correlation with long-term follow-up Clin Cancer Res 9 2003 4125 4131.
31. K. Gohji, S. Kitazawa, H. Tamada, Y. Katsuoka, and M. Nakajima Expression of endothelin receptor a associated with prostate cancer progression J Urol 165 2001 1033 1036.
32. T. Hagemann, C. Binder, L. Binder, T. Pukrop, L. Trümper, and M.J. Grimshaw Expression of endothelins and their receptors promotes an invasive phenotype of breast tumor cells but is insufficient to induce invasion in benign cells DNA Cell Biol 24 2005 766 776.
33. C. Wülfing, E. Eltze, J. Yamini, P. Wulfing, S. Bierer, and W. Bocker et al. Expression of the endothelin axis in bladder cancer: relationship to clinicopathologic parameters and long-term survival Eur Urol 47 2005 593 600.
34. E. Eltze, M. Bertolin, E. Korsching, P. Wülfing, T. Maggino, and R. Lellé Expression and prognostic relevance of endothelin-B receptor in vulvar cancer Oncol Rep 18 2007 305 311